Vascular resistance of central retinal and ophthalmic arteries in postmenopausal women after use of tibolone

Menopause

Volumn 19, Issue 3, 2012, Pages 328-331

  De Souza, Marco Aurélio Martins ^a   De Souza, Bruno Martins ^b   Geber, Selmo ^b  

^a UNIMONTES Medical School   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Central retinal artery; Menopause; Ophthalmic artery; Tibolone; Vascular resistance

Indexed keywords

FOLLITROPIN; TIBOLONE;

ADULT; ARTICLE; CENTRAL RETINA ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOOCULOGRAPHY; FEMALE; HEART RATE; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; OPHTHALMIC ARTERY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PROSPECTIVE STUDY; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ESTROGEN RECEPTOR MODULATORS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; NORPREGNENES; OPHTHALMIC ARTERY; POSTMENOPAUSE; RETINAL ARTERY; ULTRASONOGRAPHY, DOPPLER; VASCULAR RESISTANCE;

EID: 84857640538     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3182290b26     Document Type: Article

References (29)

1. Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2009;2:CD004143.
2. Cummings SR, Ettinger B, Delmas PD, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697-708.
3. Botsis D, Christodoulakos G, Papagianni V, et al. The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study. Maturitas 2006;53:362-368. (Pubitemid 43163073)
4. Campisi R, Marengo FD. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovasc Drug Rev 2007;25: 132-145. (Pubitemid 47035424)
5. Maudelonde T, Brouillet JP, Pujol P. Anti-estrogens, selective estrogen receptor modulators (SERM), tibolone: modes of action [in French]. Contracept Fertil Sex 1999;27:620-624.
6. Garefalakis M, Hickey M. Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence. Clin Interv Aging 2008;3:1-8. (Pubitemid 351559798)
7. Kloosterboer HJ. Tibolone is not aromatized in postmenopausal women. Climacteric 2008;11:175. (Pubitemid 351451115)
8. Cicinelli E, Ranieri G, Maffei S, et al. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women. Fertil Steril 2006;86:899-904. (Pubitemid 44485054)
9. Castelo-Branco C, Casals E, Figueras F, et al. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B. Menopause 1999;6:92-97. (Pubitemid 29266666)
10. Zandberg P, Peters JLM, Demacker PN, de Reeder EG, Smit MJ, Meuleman DG. Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits. Menopause 2001;8:96-105. (Pubitemid 32199674)
11. Haenggi W, Bersinger NA, Mueller MD, Birkhaeuser MH. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol Endocrinol 1999;13:202-205. (Pubitemid 29313220)
12. Cicinelli E, Ignarro LJ, Galantino P, Pinto V, Barba B, Schonauer S. Effects of tibolone on plasma levels of nitric oxide in postmenopausal women. Fertil Steril 2002;78:464-468.
13. Carranza-Lira S, Cuan-Martinez JR, Rosales-Ortiz S. Brachial artery responses in menopausal women using tibolone. Int J Gynaecol Obstet 2008;101:43-46.
14. Battaglia C, Mancini F, Persico N, et al. Tibolone, oral or transdermal hormone replacement and colour Doppler analysis: a prospective, randomised pilot study. Maturitas 2004;48:446-455. (Pubitemid 38993260)
15. Castelo-Branco C, Garcia-Fantini M, Haya J. Vascular reactivity and atheromatous plaques in post-menopausal women on tibolone treatment. Open prospective study with Doppler ultrasonography in internal carotid artery. Maturitas 2005;50:259-265. (Pubitemid 40365028)
16. Grinbaum ML, de S Ferreira JA, Fernandes CE, de Azevedo LH. Evaluation of tibolone effect on arterial resistance in postmenopausal women. Climacteric 2003;6:151-158. (Pubitemid 36714088)
17. Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy. Climacteric 2002;5:259-265.
18. Doren M, Rubig A, Coelingh Bennink HJ, Holzgreve W. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Am J Obstet Gynecol 2000;183:575-582.
19. Belfort MA, Saade GR, Snabes M, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995;172: 1273-1278.
20. Viana LC, Faria M, Pettersen H, Sampaio M, Geber S. Menstrual phaserelated differences in the pulsatility index on the central retinal artery suggest an oestrogen vasodilatation effect that antagonizes with progesterone. Arch Gynecol Obstet 2011;283:569-573.
21. Mikkonen RH, Kreula JM, Virkkunen PJ. Reliability of Doppler ultrasound in follow-up studies. Acta Radiol 1998;39:193-199. (Pubitemid 128452452)
22. Zaidi J, Jurkovic D, Campbell S, Okokon E, Tan SL. Circadian variation in uterine artery blood flow indices during the follicular phase of the menstrual cycle. Ultrasound Obstet Gynecol 1995;5:406-410.
23. Altintas O, Caglar Y, Yuksel N, Demirci A, Karabas L. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004;218:120-129. (Pubitemid 38344103)
24. Ahmed B, Bairey Merz CN, Johnson BD, et al. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood InstituteYsponsored WISE study). Am J Cardiol 2008;102:150-154.
25. Judd HL. Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 1976;19:775-788. (Pubitemid 8007370)
26. Battaglia C, Regnani G, Artini PG, et al. Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy. Gynecol Endocrinol 1999;13:223-229. (Pubitemid 29438334)
27. van Baal WM, Kenemans P, Stehouwer CD, Peters-Muller ER, van Vugt JM, van der Mooren MJ. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women. Am J Obstet Gynecol 1999; 181:1365-1373. (Pubitemid 30021878)
28. Baxter GM, Williamson TH. Color Doppler imaging of the eye: normal ranges, reproducibility, and observer variation. J Ultrasound Med 1995; 14:91-96.
29. Ustymowicz A. Color Doppler ultrasound examinations of the eye and orbitYpersonal experience and literature review [in Polish]. Klin Oczna 2008;110:108-111.